These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14605181)

  • 1. Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
    Serrano MC; Morilla D; Valverde A; Chávez M; Espinel-Ingroff A; Claro R; Ramírez M; Mazuelos EM
    J Clin Microbiol; 2003 Nov; 41(11):5270-2. PubMed ID: 14605181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
    Pfaller JB; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
    J Clin Microbiol; 2003 Mar; 41(3):1126-9. PubMed ID: 12624040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.
    Castro C; Serrano MC; Flores B; Espinel-Ingroff A; Martín-Mazuelos E
    J Clin Microbiol; 2004 Sep; 42(9):4358-60. PubMed ID: 15365044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Chryssanthou E; Cuenca-Estrella M
    Clin Microbiol Infect; 2006 Sep; 12(9):901-4. PubMed ID: 16882296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs.
    Pfaller MA; Messer SA; Mills K; Bolmström A
    J Clin Microbiol; 2000 Sep; 38(9):3359-61. PubMed ID: 10970383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.
    Espinel-Ingroff A; Rezusta A
    J Clin Microbiol; 2002 Jun; 40(6):2101-7. PubMed ID: 12037072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.
    Maesaki S; Iwakawa J; Higashiyama Y; Miyazaki Y; Yanagihara K; Tomono K; Tashiro T; Kohno S
    J Infect Chemother; 2000 Jun; 6(2):101-3. PubMed ID: 11810544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Pfaller MA; Duncanson F; Messer SA; Moet GJ; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5155-8. PubMed ID: 21844312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.
    Pfaller MA; Messer SA; Boyken L; Hollis RJ; Diekema DJ
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):241-4. PubMed ID: 12729993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
    Maxwell MJ; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
    J Clin Microbiol; 2003 Jan; 41(1):97-9. PubMed ID: 12517832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
    Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):211-4. PubMed ID: 11777662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
    Espinel-Ingroff A; Diekema DJ; Fothergill A; Johnson E; Pelaez T; Pfaller MA; Rinaldi MG; Canton E; Turnidge J
    J Clin Microbiol; 2010 Sep; 48(9):3251-7. PubMed ID: 20592159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R; Pina-Vaz C; Rodrigues AG
    Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the semisolid agar antifungal susceptibility test with the NCCLS M38-P broth microdilution test for screening of filamentous fungi.
    Kuzucu C; Rapino B; McDermott L; Hadley S
    J Clin Microbiol; 2004 Mar; 42(3):1224-7. PubMed ID: 15004080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.